Biotech Investments S.R.O
Venture studioPrague · Pre-Seed–Seed · 9 people tracked
Investment thesis
i&i Prague operates as a biotech incubator and venture builder focused on commercialising early-stage life sciences innovation, including drug development, diagnostics, and medical technologies. It provides step-by-step support to scientists setting up companies, offering expert consulting across scientific, legal, and business areas. The organization emphasizes building a network of startups, investors, industrial partners, and biotechnology experts to enable collaboration and knowledge sharing. Its incubation program helps founders access market analysis, early industry feedback, initial funding, and connections to first investors.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website
What they invest in
from 16 of 18 portfolio companiesBiotech ×15Medical Devices ×9Healthtech ×7Deep Tech ×6New Materials ×5AI & Machine Learning ×3Consumer ×1Digital Health ×1
HQs:Czechia×9Germany×1European Union×1France×1United States×1
Investments · 18 tracked
founders shown can be your intro pathAdalid Sciences engineers lipid nanoparticles to improve the delivery and efficacy of gene therapies, targeting better therapeutic outcomes with reduced side effects.
BiotechDeep TechMedical DevicesPrague, CZ
Petr Cigler(Co-Founder and Chief Scientific Officer)Frantisek Sedlak(Co-Founder and Chief Medical Officer)David Schreib(Co-Founder and Chief Commercial Officer)inKlara Grantz Saskova(Co-Founder and Chief Executive Officer)
CasInvent Pharma develops pharmaceutical solutions, currently raising Series A funding through a crowdfunding campaign.
BiotechHealthtech
Alexander Scheer(CEO)in
Co-investorsJIC Ventures
CLLEVERT develops laboratory instrumentation and diagnostic technology solutions, with expertise in biochemistry, materials science, and clinical diagnostics.
BiotechDeep TechHardwareMedical DevicesPrague, CZ
Jiří Moos(Managing Director, Founder)
Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises.
AI & Machine LearningBiotechDeep Tech
Jan Macek(Chief Executive Officer)Miroslav Lžičař(Chief Technical Officer)inJiří Růžička(Chief Business Officer)in
DIANA Biotechnologies is a Czech biotech company that sells products and services to the life sciences research market through a distributed network of regional distributors and scientific marketplaces.
BiotechHealthtechMedical DevicesVestec, CZ
Martin Dienstbier(Co-CEO)
Co-investorsB3 Holding
Dracen Pharmaceuticals is a private drug developer working at the intersection of cancer metabolism and immuno-oncology, developing glutamine antagonists that inhibit tumor glutamine metabolism and remodel the tumor microenvironment.
BiotechHealthtechBaltimore, US
Robert Wild(Co-founder & Chief Scientific Officer)Thomas M. Estok(Chief Executive Officer, President and Treasurer)Drew Pardoll, M.D., Ph.D.(Director)
BoardJonathan Leff(Director)Robert Jackson(Director)
Co-investorsOUP (Osage University Partners)Deerfield Management Company
Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients.
BiotechDigital HealthMedical DevicesPrague, CZ
Marek Minárik(Co-founder)
FUNBRUSH develops an antifouling and antibacterial nanocoating for biosensors and bioanalytical platforms, enabling sensitive detection in complex, undiluted sample media such as blood plasma, food, and environmental samples.
BiotechHealthtechNew Materials
Hana Lísalová(Founder & Head of Laboratory)
LAM-X develops nanofiber materials using patented light-activated photosensitizer technology that generates reactive oxygen species to kill microorganisms, applied to antimicrobial textiles and medical devices such as intravenous catheter dressings.
BiotechMedical DevicesNew MaterialsZlatníky-Hodkovice, CZ
Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery.
BiotechMedical DevicesNew Materials
PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsItalian Angels for GrowthDoorwaySeventure PartnersCAP HORN VC
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk.
BiotechConsumerHealthtechMedical DevicesNew MaterialsWellness & FitnessHalle (Saale), DE
Pierre Tangermann(CEO)Dr. Mirko Buchholz(Chief Scientific Officer)Dr. Nadine Taudte(Head of Biological Research)Jean-Marie Bryl(Head of Communications & Public Affairs)in
Co-investorsCompanisto
Sampling Human develops systems to generate actionable insights from individual biology using cellular-resolution data collection technologies.
AI & Machine LearningBiotechHealthtech
Daniel Georgiev(Co-Founder, CEO, and Board Member)inHynek Kasl(Co-Founder and Head of Engineering)inMartin Cienciala(Co-Founder and Head of Innovation)
Co-investorsB3 Holding
Sophomer develops polymeric materials designed to replace bovine serum albumin in immunochemical assays.
BiotechMedical DevicesNew Materials
Institute of Organic Chemistry and Biochemistry (IOCB) is a research institution under the Czech Academy of Sciences conducting basic research at the intersection of chemistry, biology, and computational sciences, with a systematic infrastructure for translating scientific discoveries into commercial products and technologies.
AI & Machine LearningBiotechDeep TechPrague, CZ
Frequently asked questions
- How many investments has Biotech Investments S.R.O made?
- Biotech Investments S.R.O has 18 tracked investments.
- What stage does Biotech Investments S.R.O invest at?
- Biotech Investments S.R.O invests at the Pre-Seed, Seed stages.
- What sectors does Biotech Investments S.R.O focus on?
- Biotech Investments S.R.O focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Biotech Investments S.R.O located?
- Biotech Investments S.R.O is headquartered in Prague, CZ.
- Who does Biotech Investments S.R.O co-invest with?
- Biotech Investments S.R.O most often shares deals with B3 Holding, Companisto, Italian Angels for Growth, among 5 tracked co-investors.
Images
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.